Pulmonx Goodwill and Intangible Assets 2019-2025 | LUNG

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pulmonx goodwill and intangible assets from 2019 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Pulmonx goodwill and intangible assets from 2019 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields

Related Stocks
Company Name	Market Cap
Veeva Systems (VEEV)	$46.1B
Tempus AI (TEM)	$13.3B
Doximity (DOCS)	$12B
Hims & Hers Health (HIMS)	$9.9B
IRhythm Technologies (IRTC)	$5.4B
Hinge Health (HNGE)	$4.4B
Inspire Medical Systems (INSP)	$2.7B
Privia Health (PRVA)	$2.6B
Heartflow (HTFL)	$2.3B
Phreesia (PHR)	$1.7B
Enovis (ENOV)	$1.7B
10x Genomics (TXG)	$1.6B
Omnicell (OMCL)	$1.5B
Schrodinger (SDGR)	$1.4B
Azenta (AZTA)	$1.4B
Clover Health Investments (CLOV)	$1.3B
Claritev (CTEV)	$1.1B
Evolent Health (EVH)	$1B
Fulgent Genetics (FLGT)	$655M
Zepp Health (ZEPP)	$580M
Veradigm (MDRX)	$525M
Standard BioTools (LAB)	$458M
Talkspace (TALK)	$456M
Butterfly Network (BFLY)	$350M
Carlsmed (CARL)	$342M
TruBridge (TBRG)	$296M
Outset Medical (OM)	$243M
SOPHiA GENETICS SA (SOPH)	$232M
Nyxoah SA (NYXH)	$216M
Health Catalyst (HCAT)	$215M